But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

A neurologist who underwent genetic testing believed he would develop Alzheimer's disease after gradually losing his sense of ...

AI is becoming more prevalent in healthcare. A new tool for helping families with a member who has dementia is now available from the Alzheimer's Foundation of America.

Adapting activities for individuals with Alzheimer's disease is essential for maintaining their engagement and well-being. As Alzheimer's progresses, activities that were once routine can become ...

President Biden on Wednesday reauthorized a bipartisan law funding public health initiatives designed to combat Alzheimer's ...

A recent study found that relatively healthy obesity may reduce the risk of developing Alzheimer's disease. Biden commutes ...

Dr Daniel Gibbs, 74, from Portland, Oregon, USA, was diagnosed with Alzheimer's disease nine years ago after realising he ...

The federal Food & Drug Administration has approved two new Alzheimer’s medications that can offer people more time to live ...

A new law is promising more help, and more funding, for the treatment and prevention of Alzheimer’s disease. The law, backed ...

Older Black and Latino people are significantly more likely to get diagnosed with Alzheimer's Disease than older white people ...

Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart ...

The Alzheimer's Association programming director provides gift ideas for those with Alzheimer's disease or dementia.